Evidence map›Paper›PMID 19931629›Full record

ReviewSeminars in cell & developmental biology2010

Proteoglycans: master modulators of paracrine fibroblast-carcinoma cell interactions.

Andreas Friedl

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in cell & developmental biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Proteoglycans in prostate cancer.Nature reviews. Urology · 2012
    Review
  2. Review
  3. The extracellular matrix at a glance.Journal of cell science · 2010
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Andreas FriedlDepartment of Pathology and Laboratory Medicine, 6051 Wisconsin Institutes for Medical Research, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI 53705-2275, United States. afriedl@wisc.edu
Wisconsin Institutes for Discovery · US

Funding

Syndecan-1 in Stromal Fibroblasts of Breast CarcinomasR01CA107012 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI FRIEDL, ANDREAS · 2005 to 2014
$2.8M
NCI NIH HHS R01 CA107012
6 · The paper itself

Abstract

Reciprocal interactions between tumor and stromal cells govern carcinoma growth and progression. Signaling functions between these cell types in the tumor microenvironment are largely carried out by secreted growth factors and cytokines. This review discusses how proteoglycans, which are abundantly present in normal and neoplastic tissues, modulate paracrine growth factor signaling events. General principles of proteoglycan involvement in paracrine signaling include stromal induction, core protein processing by proteases and growth factor binding via proteoglycan glycosaminoglycan chains or core protein domains.

Indexed as

NeoplasmsAnimalsExtracellular MatrixFibroblastsHumansIntercellular Signaling Peptides and ProteinsParacrine CommunicationProteoglycansStromal CellsIntercellular Signaling Peptides and ProteinsProteoglycans

Identifiers

PMID19931629
PMCPMC2824000
OpenAlexW2032492952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.